Efficacy of keratinocyte growth factor (palifermin) for the treatment of caustic esophageal burns

Numanoğlu,Kemal  Varim; Tatli,Duygu; Bektaş,Sibel; Er,Ebubekir

doi:10.3892/etm.2014.1851

Efficacy of keratinocyte growth factor (palifermin) for the treatment of caustic esophageal burns

Authors:
- Kemal Varim Numanoğlu
- Duygu Tatli
- Sibel Bektaş
- Ebubekir Er
View Affiliations

Affiliations: Department of Pediatric Surgery, Faculty of Medicine, Bülent Ecevit University, Kozlu, Zonguldak 67600, Turkey, Department of Pathology, Faculty of Medicine, Bülent Ecevit University, Kozlu, Zonguldak 67600, Turkey
Published online on: July 17, 2014 https://doi.org/10.3892/etm.2014.1851
Pages: 1087-1091

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Current treatment strategies against the development of corrosive esophageal strictures remain unsatisfactory. Thus, the aim of the present study was to investigate the efficacy of keratinocyte growth factor, in the form of palifermin, for the prevention of stricture development following esophageal caustic injuries in a rat model. A total of 32 female Wistar albino rats were divided into four groups, which included the control (C), burn (B), steroid (S) and steroid plus palifermin (S/P) groups. An experimental corrosive esophageal burn model was established in the B, S and S/P groups. Weight gain was recorded and histopathological evaluation was performed for each group. Weight gain in the S and B groups was compared with the control group and statistically significant differences were observed. In addition, statistically significant differences in weight gain were observed between the S/P group and the B group. Histopathologically, statistically significant differences were identified with regard to submucosal collagen deposition, muscularis mucosa and tunica muscularis damage when comparing the B group with the C group. In addition, statistically significant differences were observed when comparing the S and S/P groups with the B group. Furthermore, significant submucosal collagen deposition and tunica muscularis damage were observed in the S group when compared with the S/P group. The stenosis indexes in the C and S groups were significantly lower compared with the B group. In addition, the stenosis index in the S/P group was significantly lower compared with the S group. To the best of our knowledge, the present study is the first to investigate the effect of palifermin on corrosive esophageal burns. The addition of palifermin to the corrosive esophageal burn standard treatment regimen was found to reduce the degree of fibrosis and ameliorate histopathological damage in an experimental model of corrosive esophagitis in rats.

View Figures

View References

1	Millar AJW and Cywes S: Caustic strictures of esophagus. Pediatric Surgery. O’Neill JJ, Rowe MI, Grosfeld JL, et al: Mosby; St Louis, MO: pp. 969–979. 1998
2	Tiryaki T, Livanelioğlu Z and Atayurt H: Early bougienage for relief of stricture formation following caustic esophageal burns. Pediatr Surg Int. 21:78–80. 2005. View Article : Google Scholar : PubMed/NCBI
3	Han Y, Cheng QS, Li XF and Wang XP: Surgical management of esophageal strictures after caustic burns: a 30 years of experience. World J Gastroenterol. 10:2846–2849. 2004.PubMed/NCBI
4	Anderson KD, Rouse TM and Randolph JG: A controlled trial of corticosteroids in children with corrosive injury of the esophagus. N Engl J Med. 323:637–640. 1990. View Article : Google Scholar : PubMed/NCBI
5	Cakmak M, Nayci A, Renda N, Erekul S, Gökçora H and Yücesan S: The effect of corticosteroids and pentoxifiline in caustic esophageal burns. Int Surg. 82:371–375. 1997.PubMed/NCBI
6	Ekingen G, Ozden M, Sözübir S, Maral H, Müezzinoğlu B, Kahraman H and Güvenç BH: Effect of the prostacyclin derivate iloprost in experimental caustic esophageal burn. Pediatr Surg Int. 21:441–444. 2005. View Article : Google Scholar : PubMed/NCBI
7	Beawen AW and Shea TC: The effect of palifermin on chemotherapy and radiation therapy induced mucositis: A review of the current literature. Support Cancer Ther. 4:188–197. 2007. View Article : Google Scholar
8	Werner S: Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev. 9:153–165. 1998. View Article : Google Scholar : PubMed/NCBI
9	Radtke ML and Kolesar JM: Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support. J Oncol Pharm Pract. 11:121–125. 2005. View Article : Google Scholar : PubMed/NCBI
10	Gehanno G and Guedon C: Inhibition of experimental esophageal lye strictures by penicillamine. Arch Otolaryngol. 107:145–147. 1981. View Article : Google Scholar : PubMed/NCBI
11	Liu AJ and Richardson MA: Effects of N-acetylcysteine of experimentally induced esophageal lye injury. Ann Otol Rhinol Laryngol. 94:477–482. 1985.PubMed/NCBI
12	Berthet B, Di Costanzo J, Arnaud C, et al: Influence of epidermal growth factor and interferon gamma on healing of oesophageal corrosive burns in the rat. Br J Surg. 81:395–398. 1994. View Article : Google Scholar : PubMed/NCBI
13	Temir ZG, Karkınel A, Karaca I, Ortaç R and Ozdamar A: The effectiveness of sucralfate against stricture formation in experimental corrosive esophageal burns. Surg Today. 35:617–622. 2005. View Article : Google Scholar : PubMed/NCBI
14	Kiyan G, Aktas S, Ozel K, Isbilen E, Kotiloglu E and Dagli TE: Effects of hyperbaric oxygen therapy on caustic esophageal injury in rats. J Pediatr Surg. 39:1188–1193. 2004. View Article : Google Scholar : PubMed/NCBI
15	Günel E, Cağlayan F, Cağlayan O, Canbilen A and Tosun M: Effect of antioxidant therapy on collogen synthesis in corrosive esophageal burns. Pediatr Surg Int. 18:24–27. 2002.PubMed/NCBI
16	Koltuksuz U, Mutuş M, Kutlu R, Ozyurt C, et al: Effects of caffeic acid phenethyl ester and epidermal growth factor on development of caustic esophageal stricture in rats. J Pediatr Surg. 36:1504–1509. 2001. View Article : Google Scholar : PubMed/NCBI
17	Ozçelik MF, Pekmezci S, Saribeyoğlu K, et al: The effect of halofuginone, a specific inhibitor of collogen type 1 synthesis, in the prevention of esophageal strictures related to caustic injury. Am J Surg. 187:257–260. 2004.PubMed/NCBI
18	Wijburg FA, Heymans HS and Urbanus NA: Caustic esophageal lesions in childhood: prevention of stricture formation. J Pediatr Surg. 24:171–173. 1989. View Article : Google Scholar : PubMed/NCBI
19	Fell SC, Denize A, Becker NH and Hurwitt ES: The effect of intraluminal splinting in the prevention of caustic stricture of the esophagus. J Thorac Cardiovasc Surg. 52:675–681. 1966.PubMed/NCBI
20	Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S and Aaronson SA: Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci USA. 86:802–806. 1989. View Article : Google Scholar : PubMed/NCBI
21	Baatar D, Kawanaka H, Szabo IL, et al: Esophageal ulceration activates keratinocyte growth factor and its receptor in rats: implications for ulcer healing. Gastroenterology. 122:458–468. 2002. View Article : Google Scholar : PubMed/NCBI
22	Brauchle M, Fässler R and Werner S: Suppression of keratinocyte growth factor expression by glucocorticoids in vitro and during wound healing. J Invest Dermatol. 105:579–584. 1995. View Article : Google Scholar : PubMed/NCBI
23	Panoskaltsis-Mortari A, Taylor PA, Rubin JS, et al: Keratinocyte growth factor facilitates alloengraftment and ameliorates graft-versus-host disease in mice by a mechanism independent of repair of conditioning-induced tissue injury. Blood. 96:4350–4356. 2000.
24	Ellison CA, Natuik SA, Fischer JM, et al: Effect of recombinant human keratinocyte growth factor (rHuKGF) on the immunopathogenesis of intestinal graft-vs. -host disease induced without a preconditioning regimen. J Clin Immunol. 24:197–211. 2004. View Article : Google Scholar
25	Stout A, Gresser I and Thompson WD: Inhibition of wound healing in mice by local interferon alpha/beta injection. Int J Exp Pathol. 74:79–85. 1993.PubMed/NCBI